2022 Q1 Form 10-Q Financial Statement

#000156459022019671 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $244.0K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.271M $3.850M
YoY Change 10.94% 0.79%
% of Gross Profit
Research & Development $11.74M $11.18M
YoY Change 4.99% -11.81%
% of Gross Profit
Depreciation & Amortization $601.0K $630.0K
YoY Change -4.6% -5.55%
% of Gross Profit
Operating Expenses $11.74M $15.03M
YoY Change -21.9% -8.9%
Operating Profit -$15.77M
YoY Change
Interest Expense $66.00K $60.00K
YoY Change 10.0% -89.47%
% of Operating Profit
Other Income/Expense, Net $68.00K $60.00K
YoY Change 13.33% -89.47%
Pretax Income -$15.70M -$14.97M
YoY Change 4.86% -5.43%
Income Tax
% Of Pretax Income
Net Earnings -$15.70M -$14.97M
YoY Change 4.85% -5.41%
Net Earnings / Revenue -6433.2%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$218.1K -$360.3K
COMMON SHARES
Basic Shares Outstanding 71.97M
Diluted Shares Outstanding 71.97M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.5M $94.35M
YoY Change 27.73% -17.38%
Cash & Equivalents $21.95M $26.70M
Short-Term Investments $99.67M $67.65M
Other Short-Term Assets $3.900M $6.800M
YoY Change -42.65% -48.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $124.4M $101.2M
YoY Change 22.95% -20.57%
LONG-TERM ASSETS
Property, Plant & Equipment $23.98M $10.17M
YoY Change 135.65% -65.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $10.92M $4.000K
YoY Change 272800.0% -99.97%
Total Long-Term Assets $34.89M $34.55M
YoY Change 0.99% -20.94%
TOTAL ASSETS
Total Short-Term Assets $124.4M $101.2M
Total Long-Term Assets $34.89M $34.55M
Total Assets $159.3M $135.7M
YoY Change 17.36% -20.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.409M $1.563M
YoY Change 54.13% -8.06%
Accrued Expenses $6.929M $2.802M
YoY Change 147.29% -37.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.00K $0.00
YoY Change -100.0%
Total Short-Term Liabilities $9.664M $6.986M
YoY Change 38.33% 2.74%
LONG-TERM LIABILITIES
Long-Term Debt $15.00K $0.00
YoY Change
Other Long-Term Liabilities $17.34M $131.0K
YoY Change 13133.59% -99.41%
Total Long-Term Liabilities $17.35M $19.71M
YoY Change -11.96% -11.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.664M $6.986M
Total Long-Term Liabilities $17.35M $19.71M
Total Liabilities $27.02M $26.70M
YoY Change 1.2% -7.95%
SHAREHOLDERS EQUITY
Retained Earnings -$306.6M -$245.3M
YoY Change 24.99%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $132.3M $109.1M
YoY Change
Total Liabilities & Shareholders Equity $159.3M $135.7M
YoY Change 17.4% -20.69%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$15.70M -$14.97M
YoY Change 4.85% -5.41%
Depreciation, Depletion And Amortization $601.0K $630.0K
YoY Change -4.6% -5.55%
Cash From Operating Activities -$15.48M -$13.98M
YoY Change 10.74% 12.0%
INVESTING ACTIVITIES
Capital Expenditures $477.0K $21.00K
YoY Change 2171.43% -92.11%
Acquisitions
YoY Change
Other Investing Activities $20.24M $180.0K
YoY Change 11141.67% -97.04%
Cash From Investing Activities $19.76M $154.0K
YoY Change 12729.87% -97.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 132.0K 8.019M
YoY Change -98.35% -11721.74%
NET CHANGE
Cash From Operating Activities -15.48M -13.98M
Cash From Investing Activities 19.76M 154.0K
Cash From Financing Activities 132.0K 8.019M
Net Change In Cash 4.413M -5.803M
YoY Change -176.05% -13.79%
FREE CASH FLOW
Cash From Operating Activities -$15.48M -$13.98M
Capital Expenditures $477.0K $21.00K
Free Cash Flow -$15.95M -$14.00M
YoY Change 13.98% 9.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
8041000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71969007
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41545050
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15997000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14980000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
147266000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
83000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
890000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11738000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4271000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3851000
CY2021Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
60000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15697000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14971000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
132294000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
115135000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
33000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-65000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
877000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14971000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
109050000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15697000
CY2022Q1 us-gaap Depreciation
Depreciation
601000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
890000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000
CY2022Q1 sybx Change In Carrying Amount Of Operating Lease Right Of Use Asset
ChangeInCarryingAmountOfOperatingLeaseRightOfUseAsset
769000
CY2021Q1 sybx Change In Carrying Amount Of Operating Lease Right Of Use Asset
ChangeInCarryingAmountOfOperatingLeaseRightOfUseAsset
462000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821000
CY2022Q1 sybx Increase Decrease In Prepaid Research And Development Net Of Current Portion
IncreaseDecreaseInPrepaidResearchAndDevelopmentNetOfCurrentPortion
-488000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1387000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1408000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-217000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-739000
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-606000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
19000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15477000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13976000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
12121000
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27091000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
32356000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25996000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1270000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
477000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19758000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
154000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000
CY2022Q1 sybx Proceeds From Employee Stock Purchases And Exercise Of Stock Options
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptions
135000
CY2021Q1 sybx Proceeds From Employee Stock Purchases And Exercise Of Stock Options
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptions
33000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
65000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8019000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4413000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5803000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17535000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33604000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21948000
CY2022Q1 sybx Assets Acquired Under Operating Lease Obligation
AssetsAcquiredUnderOperatingLeaseObligation
1773000
CY2022Q1 sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
118000
CY2021Q1 sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
3000
CY2021Q1 sybx Issuance Costs Included In Accounts Payable And Accrued Expenses
IssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
2000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2022Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
120500000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1100000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-306600000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
345000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
120236000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
890000
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4827542
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
890000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
877000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
877000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2342899
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.99
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7500000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D

Files In Submission

Name View Source Status
0001564590-22-019671-index-headers.html Edgar Link pending
0001564590-22-019671-index.html Edgar Link pending
0001564590-22-019671.txt Edgar Link pending
0001564590-22-019671-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gw5j15kfob1j000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sybx-10q_20220331.htm Edgar Link pending
sybx-10q_20220331_htm.xml Edgar Link completed
sybx-20220331.xsd Edgar Link pending
sybx-20220331_cal.xml Edgar Link unprocessable
sybx-20220331_def.xml Edgar Link unprocessable
sybx-20220331_lab.xml Edgar Link unprocessable
sybx-20220331_pre.xml Edgar Link unprocessable
sybx-ex311_8.htm Edgar Link pending
sybx-ex312_7.htm Edgar Link pending
sybx-ex321_9.htm Edgar Link pending
sybx-ex322_6.htm Edgar Link pending